Sanara MedTech (SMTI) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on Sanara MedTech (SMTI) is Neutral.

The composite score behind that read is +0.10, weighing +0.32 of bullish evidence against -0.27 bearish.

Sanara MedTech last closed at $35.07, +0.06% on the session.

Against the IVW growth benchmark the position is -0.74% over the forecast window.

The read is built from 15 underlying insights — 5 bullish and 10 bearish.

Agreement across those insights is 67%.

13 graded predictions for SMTI so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

On the fundamentals StockMap ranks Sanara MedTech in the 36th percentile on return on equity, where 100 is best.

Sanara MedTech is classified under Health Care / Health Care Equipment & Supplies, with a market capitalisation of $322.04M.

StockMap tracks Sanara MedTech as the 85th largest of the 140 companies it covers in the Health Care Equipment & Supplies industry, part of the Health Care sector.

Across that group the current two-week reads are 122 Neutral, 16 Moderate Underperform and 2 Moderate Outperform.

On that composite Sanara MedTech ranks 16th of 140 in the group, against a group median of -0.03.